Literature DB >> 10755366

Enzymatic markers of cyclosporine nephrotoxicity in patients after renal transplantation.

Z Marchewka1, J Kuźniar, A Długosz.   

Abstract

Toxicity of cyclosporine (CsA), an immunosuppressive drug widely used in transplantation, to the transplanted kidney creates a serious side effect. Therefore, searching for sensitive indicators of nephrotoxic action is well worth the effort. In this work we describe the results of estimation of urine concentration of lysosomal enzymes widely present in the kidney: N-acetyl-beta-D-glucosaminidase (NAG), its isoenzyme NAG-B and beta-glucuronidase (beta-Gr). The studies were conducted in various periods after transplantation of kidneys, on patients under various treatments and receiving different doses of CsA. The results indicate a substantial dependence of the activity of NAG and NAG-B on CsA doses and the period after transplantation. The enzyme proved to be also a sensitive indicator of graft rejection. No such dependence was observed in the case of beta-Gr.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10755366     DOI: 10.1023/a:1007181126577

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Concentrations of N-acetyl-beta-D-glucosaminidase and its intermediate isoenzymes in serum of patients with renal transplants.

Authors:  F Loko; D Robic; M T Bondiou; R Bourbouze
Journal:  Clin Chem       Date:  1991-04       Impact factor: 8.327

2.  Biochemical abnormalities in serum and urine from renal transplant recipients receiving cyclosporine.

Authors:  M C Jones; P H Whiting; A Innes; D J Propper; N Edward; G R Catto
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  Urinary enzyme excretion after donor nephrectomy.

Authors:  J S Tapson; A W Hodson; S M Marshall; R Wilkinson
Journal:  Nephron       Date:  1988       Impact factor: 2.847

4.  Differential assay of A and B isoenzymes in urinary N-acetyl-beta-D-glucosaminidase.

Authors:  M Paraire; R Bourbouze; F C Baumann; F Percheron
Journal:  Clin Chim Acta       Date:  1983-04       Impact factor: 3.786

5.  Origin and significance of urinary N-acetyl-beta, D-glucosaminidase (NAG) in renal patients with proteinuria.

Authors:  M G Costigan; R Rustom; J M Bone; A Shenkin
Journal:  Clin Chim Acta       Date:  1996-11-29       Impact factor: 3.786

6.  Cyclosporine-induced changes in glomerular filtration rate and urea excretion.

Authors:  D A Laskow; J J Curtis; R G Luke; B A Julian; P Jones; M H Deierhoi; W H Barber; A G Diethelm
Journal:  Am J Med       Date:  1990-05       Impact factor: 4.965

Review 7.  Cyclosporine-induced renal dysfunction in experimental animals and humans.

Authors:  G Remuzzi; N Perico
Journal:  Kidney Int Suppl       Date:  1995-12       Impact factor: 10.545

8.  Cyclosporine and experimental renal ischemic injury.

Authors:  S S Chow; P Thorner; R Baumal; D R Wilson
Journal:  Transplantation       Date:  1986-02       Impact factor: 4.939

9.  Nephrotoxicity of cyclosporine in humans: effect of cyclosporine on glomerular filtration and proximal tubular reabsorption.

Authors:  P Heering; P Schadewaldt; D Bach; B Grabensee
Journal:  Clin Investig       Date:  1993-12

10.  Usefulness of the assessment of urinary enzymes and microproteins in monitoring ciclosporin nephrotoxicity.

Authors:  G Tataranni; G Zavagli; R Farinelli; F Malacarne; O Fiocchi; L Nunzi; P Scaramuzzo; R Scorrano
Journal:  Nephron       Date:  1992       Impact factor: 2.847

View more
  4 in total

1.  Enzymuria and beta2-mikroglobulinuria in the assessment of the influence of proteinuria on the progression of glomerulopathies.

Authors:  Z Marchewka; J Kuźniar; A Długosz
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.

Authors:  Uwe Christians; Jost Klawitter; Jelena Klawitter; Nina Brunner; Volker Schmitz
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-02       Impact factor: 4.481

3.  Enzymuria and low molecular weight protein excretion as the differentiating marker of complications in the early post kidney transplantation period.

Authors:  Jakub Kuźniar; Z Marchewka; R Krasnowski; M Boratyńska; A Długosz; M Klinger
Journal:  Int Urol Nephrol       Date:  2006-12-07       Impact factor: 2.370

4.  Oxidative stress and coenzyme Q10 supplementation in renal transplant recipients.

Authors:  A Długosz; J Kuźniar; E Sawicka; Z Marchewka; J Lembas-Bogaczyk; W Sajewicz; M Boratyńska
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.